Cited by 599Cystic Fibrosis Research AdvancesBacterial biofilms and quorum sensingMicrobial Community Ecology and Physiology

The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.

Decade-long bacterial community dynamics in cystic fibrosis airways

Open access

Zhao, Jiangchao, Schloss, Patrick D., Kalikin, Linda M., Carmody, Lisa A., Foster, Bridget K., Petrosino, Joseph F., Cavalcoli, James D., VanDevanter, Donald R., Murray, Susan, Li, Jun Z., Young, Vincent B., LiPuma, John J.·2012·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.1120577109PMC PMC3326496

Open this paper in CoChat — free account

Abstract

The structure and dynamics of bacterial communities in the airways of persons with cystic fibrosis (CF) remain largely unknown. We characterized the bacterial communities in 126 sputum samples representing serial collections spanning 8-9 y from six age-matched male CF patients. Sputum DNA was analyzed by bar-coded pyrosequencing of the V3-V5 hypervariable region of the 16S rRNA gene, defining 662 operational taxonomic units (OTUs) from >633,000 sequences. Bacterial community diversity decreased significantly over time in patients with typically progressive lung disease but remained relatively stable in patients with a mild lung disease phenotype. Antibiotic use, rather than patient age or lung function, was the primary driver of decreasing diversity. Interpatient variability in community structure exceeded intrapatient variability in serial samples. Antibiotic treatment was associated with pronounced shifts in community structure, but communities showed both short- and long-term resilience after antibiotic perturbation. There was a positive correlation between OTU occurrence and relative abundance, with a small number of persistent OTUs accounting for the greatest abundance. Significant changes in community structure, diversity, or total bacterial density at the time of pulmonary exacerbation were not observed. Despite decreasing community diversity in patients with progressive disease, total bacterial density remained relatively stable over time. These findings show the critical relationship between airway bacterial community structure, disease stage, and clinical state at the time of sample collection. These features are the key parameters with which to assess the complex ecology of the CF airway.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.1120577109

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Self-citation
A new method for non-parametric multivariate analysis of variance
Anderson, M. J. (2001) · Austral Ecology · doi:10.1111/j.1442-9993.2001.01070.pp.x · Cited by 13,828
Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set
Nadkarni, M. A., Martin, F. E., Jacques, N. A., & Hunter, N. (2002) · Microbiology · doi:10.1099/00221287-148-1-257 · Cited by 1,931
Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis
Tunney, M. M., Field, T. R., Moriarty, T. F., Patrick, S., Doering, G., Muhlebach, M. S., Wolfgang, M. C., Boucher, R. C., Gilpin, D. F., McDowell, A., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1151oc · Cited by 466
Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients
Cox, M. J., Allgaier, M., Taylor, B., Baek, M. S., Huang, Y. J., Daly, R. A., Karaöz, U., Andersen, G. L., Brown, R., Fujimura, K. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011044 · Cited by 458
Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis
Harris, J. K., Groote, M. A. D., Sagel, S. D., Zemanick, E. T., Kapsner, R. K., Penvari, C., Kaess, H., Deterding, R. R., Accurso, F. J., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709804104 · Cited by 373
Characterization of Bacterial Community Diversity in Cystic Fibrosis Lung Infections by Use of 16S Ribosomal DNA Terminal Restriction Fragment Length Polymorphism Profiling
Rogers, G. B., Carroll, M. P., Serisier, D. J., Hockey, P., Jones, G., & Bruce, K. D. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.11.5176-5183.2004 · Cited by 316
A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients
Sibley, C. D., Parkins, M. D., Rabin, H. R., Duan, K., Nørgaard, J. C., & Surette, M. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804326105 · Cited by 311
Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities
Gast, C., Walker, A. W., Stressmann, F. A., Rogers, G. B., Scott, P., Daniels, T. W. V., Carroll, M. P., Parkhill, J., & Bruce, K. D. (2010) · The ISME Journal · doi:10.1038/ismej.2010.175 · Cited by 265
Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa
Klepac‐Ceraj, V., Lemon, K. P., Martin, T. R., Allgaier, M., Kembel, S. W., Knapp, A. A., Lory, S., Brodie, E., Lynch, S. V., Bohannan, B. J. M., et al. (2010) · Environmental Microbiology · doi:10.1111/j.1462-2920.2010.02173.x · Cited by 219

Show all 18 references

Sorted by citations

Items 201–300 of 594

Polymicrobial Interactions in the Cystic Fibrosis Airway Microbiome Impact the Antimicrobial Susceptibility of Pseudomonas aeruginosa
Reece, E., Bettio, P. H. D. A., & Renwick, J. (2021) · Antibiotics · doi:10.3390/antibiotics10070827 · Cited by 53
Maintenance tobramycin primarily affects untargeted bacteria in the CF sputum microbiome
Nelson, M. T., Wolter, D. J., Eng, A., Weiss, E. J., Vo, A. T., Brittnacher, M., Hayden, H. S., Ravishankar, S., Bautista, G. E., Ratjen, A., et al. (2020) · Thorax · doi:10.1136/thoraxjnl-2019-214187 · Cited by 51
Self-citation
Model Systems to Study the Chronic, Polymicrobial Infections in Cystic Fibrosis: Current Approaches and Exploring Future Directions
O’Toole, G. A., Crabbé, A., Kümmerli, R., LiPuma, J. J., Bomberger, J. M., Davies, J. C., Limoli, D. H., Phelan, V. V., Bliska, J. B., DePas, W. H., et al. (2021) · mBio · doi:10.1128/mbio.01763-21 · Cited by 50
Self-citation
The microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention
Hampton, T. H., Green, D. M., Cutting, G. R., Morrison, H. G., Sogin, M. L., Gifford, A. H., Stanton, B. A., & O’Toole, G. A. (2014) · Microbiome · doi:10.1186/2049-2618-2-14 · Cited by 50
Cystic fibrosis transmembrane conductance regulator in COPD: a role in respiratory epithelium and beyond
Mall, M. A., Criner, G. J., Miravitlles, M., Rowe, S. M., Vogelmeier, C. F., Rowlands, D. J., Schoenberger, M., & Altman, P. (2022) · European Respiratory Journal · doi:10.1183/13993003.01307-2022 · Cited by 52
Microbial Epidemiology of the Cystic Fibrosis Airways: Past, Present, and Future
Thornton, C. S., & Parkins, M. D. (2023) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0042-1758732 · Cited by 49
Novel Microbiome-Based Therapeutics for Chronic Rhinosinusitis
Cope, E. K., & Lynch, S. V. (2015) · Current Allergy and Asthma Reports · doi:10.1007/s11882-014-0504-y · Cited by 51
The cystic fibrosis airway microbiome
Rabin, H. R., & Surette, M. G. (2012) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328358d49a · Cited by 51
Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer—A review
Nagasaka, M., Sexton, R. E., Alhasan, R., Rahman, S. B., Azmi, A. S., & Sukari, A. W. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.102841 · Cited by 51
Microbiome Diagnostics
Schlaberg, R. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2019.303248 · Cited by 50
Insights into the role of the respiratory tract microbiome in defense against bacterial pneumonia
Drigot, Z., & Clark, S. E. (2024) · Current Opinion in Microbiology · doi:10.1016/j.mib.2024.102428 · Cited by 50
Antibiotic resistance in Prevotella species isolated from patients with cystic fibrosis
Sherrard, L. J., Graham, K., McGrath, S., McIlreavey, L., Hatch, J., Muhlebach, M. S., Wolfgang, M. C., Gilpin, D. F., Elborn, J. S., Schneiders, T., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt191 · Cited by 49
Antibiotic exposure and interpersonal variance mask the effect of ivacaftor on respiratory microbiota composition
Peleg, A. Y., Choo, J. M., Langan, K. M., Edgeworth, D. M., Keating, D., Wilson, J. W., Rogers, G. B., & Kotsimbos, T. C. (2017) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.08.002 · Cited by 53
The Effect of Influenza Virus on the Human Oropharyngeal Microbiome
Ramos‐Sevillano, E., Wade, W. G., Mann, A., Gilbert, A., Lambkin‐Williams, R., Killingley, B., Nguyen‐Van‐Tam, J. S., & Tang, C. M. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy821 · Cited by 48
A Pseudomonas aeruginosa Antimicrobial Affects the Biogeography but Not Fitness of Staphylococcus aureus during Coculture
Barraza, J. P., & Whiteley, M. (2021) · mBio · doi:10.1128/mbio.00047-21 · Cited by 48
Host–microbe interactions in distal airways: relevance to chronic airway diseases
Martin, C., Burgel, P., Lepage, P., Andréjak, C., Jacques de, B. L. I. C., BOURDIN, A. A., Brouard, J., Chanez, P., Dalphin, J., Deslée, G., et al. (2015) · European Respiratory Review · doi:10.1183/09059180.00011614 · Cited by 48
Functional Metagenomics of the Bronchial Microbiome in COPD
Millares, L., Pérez‐Brocal, V., Ferrari, R. G., Gallego, M., Pomares, X., García-Núñez, M., Montón, C., Capilla, S., Monsó, E., & Moyá, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144448 · Cited by 48
Cystic Fibrosis
Zemanick, E. T., & Hoffman, L. R. (2016) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2016.04.003 · Cited by 47
Host Adaptation Predisposes Pseudomonas aeruginosa to Type VI Secretion System-Mediated Predation by the Burkholderia cepacia Complex
Perault, A. I., Chandler, C. E., Rasko, D. A., Ernst, R. K., Wolfgang, M. C., & Cotter, P. A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.06.019 · Cited by 47
In it together: Candida–bacterial oral biofilms and therapeutic strategies
Hwang, G. (2022) · Environmental Microbiology Reports · doi:10.1111/1758-2229.13053 · Cited by 47
Antibiotic resistance in chronic respiratory diseases: from susceptibility testing to the resistome
Pailhories, H., Herrmann, J., Velo‐Suárez, L., Lamoureux, C., Beauruelle, C., Burgel, P., & Héry-Arnaud, G. (2022) · European Respiratory Review · doi:10.1183/16000617.0259-2021 · Cited by 46
Abundant DNase I-Sensitive Bacterial DNA in Healthy Porcine Lungs and Its Implications for the Lung Microbiome
Pezzulo, A. A., Kelly, P. H., Nassar, B. S., Rutland, C. J., Gansemer, N. D., Dohrn, C. L., Costello, A. J., Stoltz, D. A., & Zabner, J. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.01752-13 · Cited by 47
The Evolving Cystic Fibrosis Microbiome: A Comparative Cohort Study Spanning 16 Years
Acosta, N., Whelan, F., Somayaji, R., Poonja, A., Surette, M. G., Rabin, H. R., & Parkins, M. D. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201609-668oc · Cited by 46
Novel Guanidine Compound against Multidrug-Resistant Cystic Fibrosis-Associated Bacterial Species
Saeed, A., Bosch, A., Bettiol, M., González, D. N., Erben, M. F., & Lamberti, Y. (2018) · Molecules · doi:10.3390/molecules23051158 · Cited by 46
Microbiome in the pathogenesis of cystic fibrosis and lung transplant-related disease
Cribbs, S. K., & Beck, J. M. (2016) · Translational research · doi:10.1016/j.trsl.2016.07.022 · Cited by 48
Microbiological profiles of sputum and gastric juice aspirates in Cystic Fibrosis patients
Al-Momani, H., Perry, A., Stewart, C. J., Jones, R., Krishnan, A., Robertson, A. G., Bourke, S., Doe, S. J., Cummings, S. P., Anderson, A., et al. (2016) · Scientific Reports · doi:10.1038/srep26985 · Cited by 45
The role of anaerobic bacteria in the cystic fibrosis airway
Sherrard, L. J., Bell, S. C., & Tunney, M. M. (2016) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000299 · Cited by 44
A Different Microbiome Gene Repertoire in the Airways of Cystic Fibrosis Patients with Severe Lung Disease
Bacci, G., Mengoni, A., Fiscarelli, E. V., Segata, N., Taccetti, G., Dolce, D., Paganin, P., Morelli, P., Assanti, V. T. G., Alessandri, A. D., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081654 · Cited by 44
Cystic fibrosis respiratory microbiota: unraveling complexity to inform clinical practice
Caverly, L. J., & LiPuma, J. J. (2018) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2018.1513331 · Cited by 44
Self-citation
Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy
Yi, B., Dalpke, A. H., & Boutin, S. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.548613 · Cited by 44
Microbial communities in swine lungs and their association with lung lesions
Huang, T., Zhang, M., Tong, X., Chen, J., Yan, G., Fang, S., Guo, Y., Yang, B., Xiao, S., Chen, C., et al. (2018) · Microbial Biotechnology · doi:10.1111/1751-7915.13353 · Cited by 44
Ecological Succession of Polymicrobial Communities in the Cystic Fibrosis Airways
Khanolkar, R. A., Clark, S. T., Wang, P. W., Hwang, D. M., Yau, Y. C. W., Waters, V. J., & Guttman, D. S. (2020) · mSystems · doi:10.1128/msystems.00809-20 · Cited by 47
The airway microbiota in early cystic fibrosis lung disease
Frayman, K. B., Armstrong, D., Grimwood, K., & Ranganathan, S. (2017) · Pediatric Pulmonology · doi:10.1002/ppul.23782 · Cited by 44
Quantitative assessment of individual populations within polymicrobial biofilms
Lopes, S. P., Azevedo, N. F., & Pereira, M. O. (2018) · Scientific Reports · doi:10.1038/s41598-018-27497-9 · Cited by 42
The Yin and Yang of Streptococcus Lung Infections in Cystic Fibrosis: a Model for Studying Polymicrobial Interactions
Scott, J. E., & O’Toole, G. A. (2019) · Journal of Bacteriology · doi:10.1128/jb.00115-19 · Cited by 44
Decreased efficacy of antimicrobial agents in a polymicrobial environment
O’Brien, T. J., Figueroa, W., & Welch, M. (2022) · The ISME Journal · doi:10.1038/s41396-022-01218-7 · Cited by 43
Association between clinical antibiotic resistance and susceptibility ofPseudomonasin the cystic fibrosis lung
Jansen, G., Mahrt, N., Tüeffers, L., Barbosa, C., Harjes, M., Adolph, G., Friedrichs, A. K., Krenz-Weinreich, A., Rosenstiel, P. C., & Schulenburg, H. (2016) · Evolution Medicine and Public Health · doi:10.1093/emph/eow016 · Cited by 40
Cystic fibrosis in the era of precision medicine
Paranjape, S. M., & Mogayzel, P. J. (2017) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2017.03.001 · Cited by 43
The co-colonization prevalence of Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis: A systematic review and meta-analysis
Zhao, J., Cheng, W., He, X., & Liu, Y. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.09.010 · Cited by 39
Self-citation
New concepts in antimicrobial resistance in cystic fibrosis respiratory infections
Dřevı́nek, P., Cantón, R., Johansen, H. K., Hoffman, L. R., Coenye, T., Burgel, P., & Davies, J. C. (2022) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2022.10.005 · Cited by 39
Analysis of Changes in Diversity and Abundance of the Microbial Community in a Cystic Fibrosis Patient over a Multiyear Period
Stokell, J. R., Gharaibeh, R. Z., Hamp, T. J., Zapata, M. J., Fodor, A. A., & Steck, T. R. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02555-14 · Cited by 40
Acquisition and adaptation of the airway microbiota in the early life of cystic fibrosis patients
Boutin, S., & Dalpke, A. H. (2017) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-016-0067-1 · Cited by 42
A retrospective analysis of the pathogens in the airways of patients with primary ciliary dyskinesia
Roden, L., Görlich, D., Omran, H., Peters, G., Große-Onnebrink, J., & Kahl, B. C. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2019.08.009 · Cited by 37
Microbiome in chronic obstructive pulmonary disease
Monsó, E. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.04.20 · Cited by 39
The lung and gut microbiome: what has to be taken into consideration for cystic fibrosis?
Héry-Arnaud, G., Boutin, S., Cuthbertson, L., Elborn, J. S., & Tunney, M. M. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.11.003 · Cited by 37
Culture-Independent Identification of Nontuberculous Mycobacteria in Cystic Fibrosis Respiratory Samples
Caverly, L. J., Carmody, L. A., Haig, S., Kotlarz, N., Kalikin, L. M., Raskin, L. M., & LiPuma, J. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153876 · Cited by 37
Self-citation
The Human Respiratory Microbiome: Implications and Impact
Mitchell, A. B., & Glanville, A. R. (2018) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1617441 · Cited by 38
Update in Cystic Fibrosis 2014
Ong, T., & Ramsey, B. W. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0656up · Cited by 36
Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline
Bacci, G., Paganin, P., Lopez, L., Vanni, C., Dalmastri, C., Cantale, C., Daddiego, L., Perrotta, G., Dolce, D., Morelli, P., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156807 · Cited by 38
Parallel Analysis of Cystic Fibrosis Sputum and Saliva Reveals Overlapping Communities and an Opportunity for Sample Decontamination
Lu, J., Carmody, L. A., Opron, K., Simon, R. H., Kalikin, L. M., Caverly, L. J., & LiPuma, J. J. (2020) · mSystems · doi:10.1128/msystems.00296-20 · Cited by 39
Self-citation
Antibiotic Treatment for Chronic Rhinosinusitis: Prescription Patterns and Associations With Patient Outcome and the Sinus Microbiota
Lux, C. A., Mackenzie, B. W., Johnston, J. J., Zoing, M., Biswas, K., Taylor, M. W., & Douglas, R. G. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.595555 · Cited by 36
Association of bacterial community types, functional microbial processes and lung disease in cystic fibrosis airways
Stefanie Widder, A., Zhao, J., Carmody, L. A., Zhang, Q., Kalikin, L. M., Schloss, P. D., & LiPuma, J. J. (2021) · The ISME Journal · doi:10.1038/s41396-021-01129-z · Cited by 36
Self-citation
Comparative genomics of non-pseudomonal bacterial species colonising paediatric cystic fibrosis patients
Ormerod, K. L., George, N., Fraser, J. A., Wainwright, C. E., & Hugenholtz, P. (2015) · PeerJ · doi:10.7717/peerj.1223 · Cited by 36
Metabolism and Pathogenicity ofPseudomonas aeruginosaInfections in the Lungs of Individuals with Cystic Fibrosis
Palmer, G. C., & Whiteley, M. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mbp-0003-2014 · Cited by 37
Diversification of Pseudomonas aeruginosa within the cystic fibrosis lung and its effects on antibiotic resistance
Clark, S. T., Guttman, D. S., & Hwang, D. M. (2018) · FEMS Microbiology Letters · doi:10.1093/femsle/fny026 · Cited by 36
Inhalation Injury: Unmet Clinical Needs and Future Research
Dyamenahalli, K. U., Garg, G., Shupp, J. W., Kuprys, P. V., Choudhry, M. A., & Kovacs, E. J. (2019) · Journal of Burn Care & Research · doi:10.1093/jbcr/irz055 · Cited by 39
Role of GM-CSF in the inflammatory cytokine network that regulates neutrophil influx into the colonic mucosa duringClostridium difficileinfection in mice
McDermott, A. J., Frank, C. R., Falkowski, N. R., McDonald, R. A., Young, V. B., & Huffnagle, G. B. (2014) · Gut Microbes · doi:10.4161/gmic.29964 · Cited by 36
Self-citation
Impact of Multidrug-Resistant Organisms on Patients Considered for Lung Transplantation
Shoham, S., & Shah, P. D. (2013) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2013.02.006 · Cited by 35
Exploring the Cystic Fibrosis Lung Microbiome: Making the Most of a Sticky Situation
Thornton, C. S., Acosta, N., Surette, M. G., & Parkins, M. D. (2022) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piac036 · Cited by 37
Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome
Bazett, M., Honeyman, L., Stefanov, A. N., Pope, C. E., Hoffman, L. R., & Haston, C. K. (2015) · Mammalian Genome · doi:10.1007/s00335-015-9560-4 · Cited by 34
The evolving dynamics of the microbial community in the cystic fibrosis lung
McGuigan, L., & Callaghan, M. (2014) · Environmental Microbiology · doi:10.1111/1462-2920.12504 · Cited by 37
Loss of Microbial Niche Specificity Between the Upper and Lower Airways in Patients With Cystic Fibrosis
Pletcher, S. D., Goldberg, A. N., & Cope, E. K. (2018) · The Laryngoscope · doi:10.1002/lary.27454 · Cited by 34
Measures of Cystic Fibrosis Airway Microbiota during Periods of Clinical Stability
Caverly, L. J., Lu, J., Carmody, L. A., Kalikin, L. M., Shedden, K., Opron, K., Azar, M., Cahalan, S. E., Foster, B. K., VanDevanter, D. R., et al. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201903-270oc · Cited by 34
Self-citation
In vitro evolution of Pseudomonas aeruginosa AA2 biofilms in the presence of cystic fibrosis lung microbiome members
Vandeplassche, E., Sass, A. M., Lemarcq, A., Dandekar, A. A., Coenye, T., & Crabbé, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-49371-y · Cited by 34
Is there a role for antibiotics in the treatment of chronic rhinosinusitis?
Smith, S. S., Kim, R., & Douglas, R. G. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.02.004 · Cited by 33
Molecular detection of CF lung pathogens: Current status and future potential
Pattison, S. H., Rogers, G. B., Crockard, M. A., Elborn, J. S., & Tunney, M. M. (2013) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2013.01.007 · Cited by 34
Antibiotic multidrug resistance in the cystic fibrosis airway microbiome is associated with decreased diversity
Hahn, A., Burrell, A., Fanous, H., Chaney, H. R., Sami, I. R., Pérez, G. F., Koumbourlis, A. C., Freishtat, R. J., & Crandall, K. A. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e00795 · Cited by 33
Pathogen to commensal? Longitudinal within-host population dynamics, evolution, and adaptation during a chronic >16-year Burkholderia pseudomallei infection
Pearson, T., Sahl, J. W., Hepp, C. M., Handady, K., Hornstra, H., Vazquez, A. J., Settles, E. W., Mayo, M. J., Kaestli, M., Williamson, C. H. D., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008298 · Cited by 34
Respiratory microbiome in IPF: cause, effect, or biomarker?
Molyneaux, P. L., & Maher, T. M. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70088-8 · Cited by 33
Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients
Sherrard, L. J., Schaible, B., Graham, K., McGrath, S., McIlreavey, L., Hatch, J., Wolfgang, M. C., Muhlebach, M. S., Gilpin, D. F., Schneiders, T., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku192 · Cited by 33
Microbiome, biofilms, and pneumonia in the ICU
Pirrone, M., Pinciroli, R., & Berra, L. M. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000255 · Cited by 37
Probiotic strategies for treatment of respiratory diseases
Nagalingam, N. A., Cope, E. K., & Lynch, S. V. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.04.008 · Cited by 32
Precision respiratory medicine and the microbiome
Rogers, G. B., & Wesselingh, S. L. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00476-2 · Cited by 35
Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System
Price, K. E., Naimie, A. A., Griffin, E. F., Bay, C., & O’Toole, G. A. (2015) · Journal of Bacteriology · doi:10.1128/jb.00705-15 · Cited by 32
The pediatric microbiome and the lung
Tracy, M. C., Cogen, J. D., & Hoffman, L. R. (2015) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000212 · Cited by 32
Microbiome in cystic fibrosis: Shaping polymicrobial interactions for advances in antibiotic therapy
Lopes, S. P., Azevedo, N. F., & Pereira, M. O. (2014) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2013.847898 · Cited by 32
Early Respiratory Bacterial Detection and Antistaphylococcal Antibiotic Prophylaxis in Young Children with Cystic Fibrosis
Hurley, M. N., Fogarty, A., McKeever, T. M., Goss, C. H., Rosenfeld, M., & Smyth, A. R. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201705-376oc · Cited by 31
One versus Many: Polymicrobial Communities and the Cystic Fibrosis Airway
Jean-Pierre, F., Vyas, A., Hampton, T. H., Henson, M. A., & O’Toole, G. A. (2021) · mBio · doi:10.1128/mbio.00006-21 · Cited by 31
The Cystic Fibrosis Upper and Lower Airway Metagenome
Pienkowska, K., Pust, M., Gessner, M., Gaedcke, S., Thavarasa, A., Rosenboom, I., Losada, P. M., Minso, R., Arnold, C., Hedtfeld, S., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03633-22 · Cited by 31
Reemergence of Lower-Airway Microbiota in Lung Transplant Patients with Cystic Fibrosis
Syed, S. A., Whelan, F., Waddell, B. J. M., Rabin, H. R., Parkins, M. D., & Surette, M. G. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201606-431oc · Cited by 31
Neutrophil elastase-mediated increase in airway temperature during inflammation
Schmidt, A., Belaaouaj, A., Bissinger, R., Koller, G., Malleret, L., D'Orazio, C., Facchinelli, M., Schulte-Hubbert, B., Molinaro, A., Holst, O., et al. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.03.004 · Cited by 30
Self-citation
Antibiotic susceptibility of cystic fibrosis lung microbiome members in a multispecies biofilm
Vandeplassche, E., Sass, A. M., Ostyn, L., Burmølle, M., Kragh, K. N., Bjarnsholt, T., Coenye, T., & Crabbé, A. (2020) · Biofilm · doi:10.1016/j.bioflm.2020.100031 · Cited by 30
Improvement of a mouse infection model to capture Pseudomonas aeruginosa chronic physiology in cystic fibrosis
Duncan, R. P., Moustafa, D. A., Lewin, G. R., Diggle, F. L., Bomberger, J. M., Whiteley, M., & Goldberg, J. B. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2406234121 · Cited by 29
A Pipeline for Screening Small Molecules with Growth Inhibitory Activity against Burkholderia cenocepacia
Selin, C., Stietz, M. S., Blanchard, J., Gehrke, S. S., Bernard, S., Hall, D. G., Brown, E. D., & Cardona, S. T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128587 · Cited by 29
Cystic Fibrosis Rapid Response: Translating Multi-omics Data into Clinically Relevant Information
Güemes, A. G. C., Lim, Y. W., Quinn, R. A., Conrad, D. J., Benler, S., Maughan, H., Edwards, R. A., Brettin, T. S., Cantu, A., Cuevas, D., et al. (2019) · mBio · doi:10.1128/mbio.00431-19 · Cited by 29
Molecular Accounting and Profiling of Human Respiratory Microbial Communities: Toward Precision Medicine by Targeting the Respiratory Microbiome for Disease Diagnosis and Treatment
Alsayed, A. R., Abed, A. I., Khader, H. A., Al-Shdifat, L., Hasoun, L., Al‐Rshaidat, M. M. D., Alkhatib, M., & Zihlif, M. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044086 · Cited by 32
Ralstonia mannitolilytica in cystic fibrosis: A new predictor of worse outcomes
Coman, I., Bilodeau, L., Lavoie, A., Carricart, M., Tremblay, F., Zlosnik, J. E. A., & Berthiaume, Y. (2016) · Respiratory Medicine Case Reports · doi:10.1016/j.rmcr.2016.11.014 · Cited by 29
Microbial diversity within the airway microbiome in chronic pediatric lung diseases
Hahn, A., Warnken, S., Pérez‐Losada, M., Freishtat, R. J., & Crandall, K. A. (2017) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2017.12.006 · Cited by 33
Interaction betweenPseudomonas aeruginosaandAspergillus fumigatusin cystic fibrosis
Zhao, J., & Yu, W. (2018) · PeerJ · doi:10.7717/peerj.5931 · Cited by 30
Self-citation
Sputum microbiota in adults with CF associates with response to inhaled tobramycin
Heirali, A., Thornton, C. S., Acosta, N., Somayaji, R., Laforest‐Lapointe, I., Storey, D. G., Rabin, H. R., Waddell, B. J. M., Rossi, L., Arrieta, M., et al. (2020) · Thorax · doi:10.1136/thoraxjnl-2019-214191 · Cited by 29
High Individuality of Respiratory Bacterial Communities in a Large Cohort of Adult Cystic Fibrosis Patients under Continuous Antibiotic Treatment
Kramer, R., Sauer‐Heilborn, A., Welte, T., Jáuregui, R., Brettar, I., Guzmán, C. A., & Höfle, M. G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117436 · Cited by 29
Longitudinal Associations of the Cystic Fibrosis Airway Microbiome and Volatile Metabolites: A Case Study
Hahn, A., Whiteson, K., Davis, T. J., Phan, J. L., Sami, I. R., Koumbourlis, A. C., Freishtat, R. J., Crandall, K. A., & Bean, H. D. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00174 · Cited by 28
Potential Contributions of Anaerobes in Cystic Fibrosis Airways
Thornton, C. S., & Surette, M. G. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.01813-19 · Cited by 29
Developing selective media for quantification of multispecies biofilms following antibiotic treatment
Vandeplassche, E., Coenye, T., & Crabbé, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187540 · Cited by 27
The sputum microbiome associated with different sub-types of AECOPD in a Chinese cohort
Wang, J., Chai, J., Sun, L., Zhao, J., & Chang, C. H. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05313-y · Cited by 27
Self-citation
ABCs of the Lung Microbiome
Beck, J. M. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201306-188mg · Cited by 29
The microbiome of the upper airways: focus on chronic rhinosinusitis
Chalermwatanachai, T., Pereira, L. C. V., & Bachert, C. (2015) · World Allergy Organization Journal · doi:10.1186/s40413-014-0048-6 · Cited by 27
Data Mining of Lung Microbiota in Cystic Fibrosis Patients
Li, J., Hao, C., Ren, L., Xiao, Y. B., Wang, J., & Qin, X. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164510 · Cited by 28
Self-citation
The effects of cycled inhaled aztreonam on the cystic fibrosis (CF) lung microbiome
Heirali, A., Acosta, N., Storey, D. G., Workentine, M. L., Somayaji, R., Laforest‐Lapointe, I., Leung, W. M., Quon, B. S., Berthiaume, Y., Rabin, H. R., et al. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.02.010 · Cited by 27
Longitudinal development of the airway microbiota in infants with cystic fibrosis
Ahmed, B., Cox, M. J., Cuthbertson, L., James, P. L., Cookson, W., Davies, J. C., Moffatt, M. F., & Bush, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-41597-0 · Cited by 27

Authors: Zhao, J., Schloss, P. D., Kalikin, L. M., Carmody, L. A., Foster, B. K., Petrosino, J. F., Cavalcoli, J. D., VanDevanter, D. R., Murray, S., Li, J. Z., Young, V. B., & LiPuma, J. J.
Affiliations: University of Michigan (US)
Microbiology and Immunology,
Baylor College of Medicine (US)
Case Western Reserve University (US)
Biostatistics and
Human Genetics, and
ORCID: Zhao, Jiangchao
Schloss, Patrick D.
Carmody, Lisa A.
Petrosino, Joseph F.
VanDevanter, Donald R.
Murray, Susan
Li, Jun Z.
Young, Vincent B.
LiPuma, John J.
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2012-03-26
Volume: 109
Issue: 15
Pages: 5809-5814
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.1120577109
PMC: PMC3326496
OpenAlex: W2094167812
Cited by: 599
References: 18
Citations by year: 2026: 12 · 2025: 18 · 2024: 32 · 2023: 31 · 2022: 37 · 2021: 41 · 2020: 57 · 2019: 57 · 2018: 40 · 2017: 39 · 2016: 50 · 2015: 61 · 2014: 63 · 2013: 43 · 2012: 18
FWCI: 47.73
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Deep Blue (University of Michigan) (submittedVersion)
Funders: National Institutes of Health (5rc1hl100809-02)
National Heart, Lung, and Blood Institute (U01HL098961, RC1-HL100809, 1RC1HL100809-01)
National Human Genome Research Institute (R01HG005975, R01HG004906)
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034933, P30DK027651)
National Center for Research Resources (UL1RR024986)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
Physical Sciences › Environmental Science › Ecology › Microbial Community Ecology and Physiology
Keywords: cystic fibrosis, sputum microbiome, bacterial diversity, antibiotic therapy, community resilience, pulmonary exacerbations, disease progression, 16S rRNA gene sequencing, interpatient variability
MeSH terms: Adolescent, Adult, Aging, Anti-Bacterial Agents, Bacteria, Cystic Fibrosis, Humans, Lung, Male, Respiratory Function Tests, Sputum, Disease Progression, Principal Component Analysis, Biodiversity, Metagenome, Young Adult, Bacterial Load

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Decade-long bacterial community dynamics in cystic fibrosis airways

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks